MEDICOVER PUBLIC CO LTD

MEDICOVER PUBLIC CO LTD operates as a biotechnology firm headquartered in Cyprus that specializes in the design, development, production, and delivery of in vitro genetic testing solutions. The company leverages its proprietary technology platform and bioinformatics tools to address various genetic conditions across the human genome, supporting applications ranging from standard DNA testing to specialized non-invasive methodologies such as NIPT and Liquid Biopsy.

The company delivers genetic testing services across more than 30 countries spanning Europe, Asia, and Africa. MEDICOVER PUBLIC CO LTD functions as a division of Medicover, a major international provider of healthcare and diagnostic services established in 1995 and traded on Nasdaq Stockholm.